奧園健康(03662.HK)目標管理面積增至7,500至8,000萬平方米
奧園健康(03662.HK)宣布增持醫美公司浙江連天美至60%,總裁蘇波透露,內地醫美行業集中度低,未有市佔率逾5%的單一機構,未來將共同發展物管、商管及大健康三項主要業務,期望未來兩年公司業績年複合增長率可達55%至60%。
他又指,未來仍會以物業管理為主業,目標管理面積達到7,500至8,000萬平方米,當中第三方佔比至少達10%,並計劃有30%來自非住宅項目;商管方面每年目標新增6至8個商場及1至2個產業運營項目。
醫美業務方面,他表示現時目標要做好手上項目,但不排除未來再有新收購及與龍頭企業合作的可能,訂立併購項目利潤增長10%至15%的目標,並期望每年新增1萬名忠誠度較高的客戶。
連天美2019年除稅後淨虧損達930萬元人民幣(下同),副總裁兼首席財務官鄭少輝解釋,主要受該公司此前新設數家醫院的投資所拖累,現時已作剝離,指出連天美今年上半年4,620萬元,料全年利潤可達7,500至8,000萬元,考慮到管理架構穩定,未有再增持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.